Research graph
References from Definitive chemoradiotherapy with low-dose continuous 5-fluorouracil reduces hematological toxicity without compromising survival in esophageal squamous cell carcinoma patients. Local targets link to admitted publications; unresolved targets remain external evidence.
A randomized phase II study of cisplatin/5-FU concurrent chemoradiotherapy for esophageal cancer: Short-term infusion versus protracted infusion chemotherapy (KROSG0101/JROSG021)
10.1016/j.radonc.2008.12.012 · 2009 · External reference
Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102
10.1200/jco.2005.04.7118 · 2007 · External reference
Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study
10.1200/jco.1997.15.1.277 · 1997 · External reference
Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus
10.1056/nejm199206113262403 · 1992 · External reference
Phase II study of chemoradiotherapy with 5-fluorouracil and cisplatin for Stage II-III esophageal squamous cell carcinoma: JCOG trial (JCOG 9906)
10.1016/j.ijrobp.2010.06.033 · 2011 · External reference
Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus
10.1200/jco.2003.03.055 · 2003 · External reference
Molecular mechanisms of resistance and toxicity associated with platinating agents
10.1016/j.ctrv.2006.09.006 · 2007 · External reference
Feasibility of chemoradiation therapy with protracted infusion of 5-fluorouracil for esophageal cancer patients not suitable for cisplatin
10.1007/s10147-005-0506-9 · 2005 · External reference
Concurrent chemoradiotherapy using low-dose continuous infusion of 5-fluorouracil for postoperative regional lymph node recurrence of esophageal squamous cell carcinoma
10.1007/s10388-005-0035-7 · 2005 · External reference
Concurrent radiotherapy and chemotherapy with protracted continuous infusion of 5-fluorouracil in inoperable esophageal squamous cell carcinoma
10.1016/0360-3016(94)00415-3 · 1995 · External reference
Cancer of the esophagus and esophagogastric junction: data-driven staging for the seventh edition of the American Joint Committee on Cancer/International Union Against Cancer Cancer Staging Manuals
10.1002/cncr.25146 · 2010 · External reference
Staging investigations for oesophageal cancer: a meta-analysis
10.1038/sj.bjc.6604200 · 2008 · External reference
Recursive partitioning analysis for new classification of patients with esophageal cancer treated by chemoradiotherapy
10.1016/j.ijrobp.2011.12.069 · 2012 · External reference
Involved-field irradiation concurrently combined with nedaplatin/5-fluorouracil for inoperable esophageal cancer on basis of (18)FDG-PET scans: a phase II study
10.1016/j.radonc.2014.11.004 · 2014 · External reference
Study to determine adequate margins in radiotherapy planning for esophageal carcinoma by detailing patterns of recurrence after definitive chemoradiotherapy
10.1016/j.ijrobp.2008.04.062 · 2009 · External reference
Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentre, phase 2/3 randomised trial
10.1016/s1470-2045(13)70136-0 · 2013 · External reference
Definitive chemoradiotherapy for T4 and/or M1 lymph node squamous cell carcinoma of the esophagus
10.1200/jco.1999.17.9.2915 · 1999 · External reference
Predictive factors of survival in patients treated with definitive chemoradiotherapy for squamous cell esophageal carcinoma
10.3748/wjg.v12.i26.4185 · 2006 · External reference
Salvage endoscopic submucosal dissection in patients with local failure after chemoradiotherapy for esophageal squamous cell carcinoma
10.3109/00365521.2013.822092 · 2013 · External reference
Standard (60 Gy) or short-course (40 Gy) irradiation plus concomitant and adjuvant temozolomide for elderly patients with glioblastoma: a propensity-matched analysis
10.1016/j.ijrobp.2014.09.013 · 2015 · External reference
Chemotherapy for advanced non-small-cell lung cancer in elderly patients
10.1001/jamaoncol.2016.2050 · 2016 · External reference
Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies
10.1002/pst.433 · 2011 · External reference
Investigation of the freely available easy-to-use software 'EZR' for medical statistics
10.1038/bmt.2012.244 · 2013 · External reference
Unresolved reference
External reference
A Multi-institutional analysis of trimodality therapy for esophageal cancer in elderly patients
10.1016/j.ijrobp.2017.02.021 · 2017 · External reference
Surgical mortality in patients with esophageal cancer: development and validation of a simple risk score
10.1200/jco.2005.05.0658 · 2006 · External reference
Long-term results of concurrent chemoradiotherapy using low-dose continuous infusion of 5-fluorouracil for stage II-III esophageal cancer
2001 · External reference
Pooled analysis of individual patient data on concurrent chemoradiotherapy for stage III non-small-cell lung cancer in elderly patients compared with younger patients who participated in US national cancer institute cooperative group studies
10.1200/jco.2016.71.4758 · 2017 · External reference
Definitive chemoradiotherapy with FOLFOX versus fluorouracil and cisplatin in patients with oesophageal cancer (PRODIGE5/ACCORD17): final results of a randomised, phase 2/3 trial
10.1016/s1470-2045(14)70028-2 · 2014 · External reference
A systematic review of acute and late toxicity of concomitant chemoradiation for cervical cancer
10.1016/s0167-8140(03)00197-x · 2003 · External reference
Feasibility of elective nodal irradiation (ENI) and involved field irradiation (IFI) in radiotherapy for the elderly patients (Aged >/= 70 years) with esophageal squamous cell cancer: a retrospective analysis from a single institute
10.1371/journal.pone.0143007 · 2015 · External reference
Pharmacologic requirements for obtaining sensitization of human tumor cells in vitro to combined 5-Fluorouracil or ftorafur and X rays
10.1016/0360-3016(82)90451-5 · 1982 · External reference
Preoperative chemoradiation in fixed distal rectal cancer: dose time factors for pathological complete response
10.1016/s0360-3016(99)00486-1 · 2000 · External reference
Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery
10.1056/nejm199408253310803 · 1994 · External reference
Primary tumor response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer: pathologic results of the STAR-01 randomized phase III trial
10.1200/jco.2010.34.4911 · 2011 · External reference
Randomized phase 2 trial of S1 and oxaliplatin-based chemoradiotherapy with or without induction chemotherapy for esophageal cancer
10.1016/j.ijrobp.2014.11.019 · 2015 · External reference
